This page is updated frequently with new Ophthalmic-related patent applications.
|Improved ophthalmic lens for presbyopia correction|
An ophthalmic lens for presbyopia correction, having at least one diffractive structure, wherein the diffractive structure has at least one region of variable diffraction efficiency in which the diffraction efficiency of at least one diffraction order of the diffractive structure that contributes to the focal power of the lens varies depending on the visual point on the ophthalmic lens.. .
|Method of modifying an dioptric function of an ophthalmic lens surface|
Alphai being a nonzero weighting coefficient.. .
|A optimising geometry of a semi-finished ophthalmic lens in a set of semi-finished ophthalmic lenses|
The present invention provides a method, a system, and a computer program code for optimising geometry of at least one semi-finished ophthalmic lens in a set of semi-finished ophthalmic lenses having a designated lens material, each of the semi-finished ophthalmic lenses in the set having an initially determined geometry including one of a plurality of base curves determined to allow manufacture of finished ophthalmic lenses for ophthalmic lens prescriptions.. .
Carl Zeiss Vision International Gmbh
|Aqueous ophthalmic composition|
An aqueous ophthalmic composition is provided comprising at least one component which is selected from the group consisting of a polysaccharide, a monosaccharide, at least one vitamin component selected from the group consisting of vitamin b12, vitamin b2, vitamin a and panthenol, at least one oil component selected from the group consisting of a plant oil, an animal oil and a mineral oil, at least one surfactant selected from the group consisting of polyoxyethylene castor oil, polyoxyethylene hydrogenated castor oil, polyoxyethylene polyoxypropylene glycol and polyoxyl stearate, an anti-allergic component, a preservative, a thickening component, a polyhydric alcohol, an anti-inflammatory component, an anti-bacterial agent and a cooling and/or refreshing agent; and (b) a buffering agent. When the composition is brought into contact with a polybutylene terephthalate-containing resin container, the container can be prevented from weight change, deterioration and wetting and can be improved in a liquid cutting property..
Rohto Pharmaceutical Co., Ltd.
|Pharmaceutical compositions comprising gels and methods for fabricating thereof|
Pharmaceutical compositions are described, the compositions comprising a therapeutically effective quantity of an active component and a quantity of a sterile gel. Methods for fabricating the compositions and using them for ophthalmic or burn-treating applications are also described..
Imprimis Pharmaceuticals, Inc.
|Aqueous ophthalmic solution of olopatadine|
An aqueous ophthalmic solution containing a relatively high concentration of olopatadine in solubilized form is provided. The solution comprises a combination of at least two non-ionic surfactants and is essentially devoid of cyclodextrins.
|Mould and process for manufacturing an ophthalmic lens equipped with an insert|
The invention relates to a mould (2) for manufacturing an ophthalmic lens or an ophthalmic lens blank called a puck (3), equipped with an insert (1), said mould comprising a first portion (2a) intended to mould the front face of the ophthalmic lens or puck, a second portion (2b) intended to mould the back face of the ophthalmic lens or puck and at least one third portion (2c) intended to mould a peripheral lateral face of the ophthalmic lens or puck. According to the invention, said mould (2) comprises at least one recess (2b1, 2b2, 2b3, 2b4) for positioning the insert (1), before and during the moulding..
Essilor International (compagnie Generale D'optique)
|Methods of treating ophthalmic diseases using npr-b agonists|
Disclosed are novel compounds having npr-b agonistic activity. Preferred compounds are linear peptides containing 8-13 conventional or non-conventional l- or d-amino acid residues connected to one another via peptide bonds..
Shire Orphan Therapies Gmbh
|Centering technique for a cutting laser for refractive ophthalmic surgery|
According to certain embodiments, a method for laser cutting treatment of a human eye comprises: determining position information of a pupil center of the eye in relation to a point of minimal corneal thickness in an undeformed state of the eye; locating the point of minimal corneal thickness in a flattened state of the eye, in which the eye is deformed by contact with a patient adapter of a laser device; and aligning a pulse firing pattern for laser radiation pulses of the laser device, based on a position of the located point of minimal corneal thickness and the determined position information. In embodiments, the pulse firing pattern represents, for example, a lenticular or doughnut-shaped intracorneal tissue volume which is to be removed from the cornea of the eye..
|A process for manufacturing an ophthalmic lens equipped with an insert|
The invention relates to a process for manufacturing an ophthalmic lens equipped with an insert (1), by means of a mold, comprising:—a step of molding a puck (3) comprising two faces (3a, 3b) and said insert (1) positioned between said faces; and—a step of machining at least one of said faces (3a, 3b) of said puck in order to form one of the front or back faces of said ophthalmic lens, the insert (1) being positioned relative to one portion of the mold before said molding step, according to the invention, an element associated with the insert or an imprint of this element left in the puck after the element has been removed comprises at least one of its portions providing a positional reference relative to said insert (1) in the machining step.. .
Essilor International (compagnie Générale D'optique)
Uv and high energy visible absorbing ophthalmic lenses
An ophthalmic lens operable to protect the eye from harmful ultraviolet and high energy visible wavelengths of light and methods for producing the same.. .
Vision Ease, Lp
Method for characterizing an ophthalmic lens
From a difference between the respective stored measured reflectivity value of the ophthalmic lens and the corresponding reference reflectivity value determining the quality of the inspected surface of the ophthalmic lens.. .
Silicone containing monomers with hydrophilic end groups
Wherein r1 is h or ch3, a is 0 or 1, p is an integer from 1 to 6, q is an integer from 1 to 3 and for each q, the end groups r51, r52, r53 are independently an alkyl, alkyl ether, urethane, trimethylsiloxy group, or a substituted or non-substituted aromatic group and at least one of them has a hydrophilic group z attached wherein said hydrophilic group z is selected from the group of poly(ethylene glycol), poly(propylene glycol), poly(ethyl oxazoline), poly(methyl oxazoline), hyaluronic acid, or combinations thereof, preferably to the terminal end of r51, r52, r53, x is o or nr54, where r54 is h or a monovalent alkyl group with 1 to 4 carbons, n is an integer from 1 to 100, r2 and r3 is independently an alkyl, alkyl ether, trimethylsiloxy group, or a substituted or non-substituted aromatic group, preferred r2 and r3 include methyl, ethyl, trimethylsiloxy and phenyl, l is a divalent linker comprising substituted and unsubstituted alkylene groups having 1-14 carbon atoms, which may be straight or branched, substituted and unsubstituted alkoxy groups having 2-12 carbons, polyethers, oxazolines, substituted and unsubstituted heterocyclic groups. The reactive monomers combine oxygen permeable silicone components with hydrophilic terminal groups capable of reaching to the device-biologic interface thus providing bulk and surface characteristics useful in the manufacture of medical devices, particularly ophthalmic devices..
Drug loaded microfiber sutures for ophthalmic application
ophthalmic suture materials made from biocompatible and biodegradable polymers with high tensile strength for use in drug delivery, methods of making them, and method of using them for ocular surgery and repair have been developed. The suture materials are made from a combination of a biodegradable, biocompatible polymer and a hydrophilic biocompatible polymer.
The Johns Hopkins University
Ophthalmic surgical cutting system with varied cross section tube-set
An ophthalmic surgical cutting apparatus. In one instance, the apparatus includes a pneumatically-powered surgical cutter driven by a pneumatic pulse generator and a tubing assembly comprising multi-stage tubing connecting the generator to the cutter.
Medical Instrument Development Laboratories, Inc.
Ophthalmic surgical apparatus
An ophthalmic surgical apparatus supplies perfusion solution into a patient's eye from a perfusion solution container stored with the perfusion solution. The ophthalmic surgical apparatus includes a perfusion passage, a non-positive displacement pump, a perfusion pressurizing motor, and a controller.
Nidek Co., Ltd.
Ophthalmic laser treatment apparatus
An ophthalmic laser treatment apparatus comprises: an observation optical system; first and second irradiation optical systems to irradiate first and second laser lights for treatment toward a patient's eye; and first and second guide optical systems to irradiate first and second guide lights toward the eye. The second irradiation optical system displaces a condensing position of the second laser light to either one of a position far from of a reference plane on which the observation optical system is focused and a position short of the reference plane, so that a spot size of the second laser light on the reference plane is increased to a larger size than a spot size of the first laser light on the reference plane.
Nidek Co., Ltd.
Container for accommodating an ophthalmic lens during a lens treatment process
A container (1) for accommodating an ophthalmic lens during a lens treatment process has a longitudinal axis (11) and comprises as separate elements a containment element (2), a mounting element (3), and a retaining element (4). The containment element (2) comprises a tubular section (21) and a bottom (22) arranged at a distal end of the tubular section (21), the bottom (22) protruding convexly towards the outside at the distal end of the tubular section (21) and being provided with a number of apertures (23, 24), the tubular section (21) at a proximal end (25) thereof having a latch (26) protruding from the proximal end (25) of the tubular section (21) towards the mounting element (3).
A process for manufacturing an ophthalmic lens equipped with an insert
The invention relates to a process for manufacturing an ophthalmic lens element equipped with an insert (1), this ophthalmic lens element comprising a front face and a back face, comprising steps consisting in: providing a first portion or intermediate product (2, 2″) made of a first material comprising a first and second frontal face (2a, 2b, 2a″, 2b″), said second face forming the back or front face of said ophthalmic lens element; placing the insert (1) on said first face of said intermediate product; depositing a second material in liquid form on said first face of the intermediate product (2, 2″) so as to cover at least partially said insert with said second material; and solidifying said second material in order to form an integral second portion (4) of said intermediate product. According to the invention, said first material is organic..
Essilor International (compagnie Générale D' Optique)
Ophthalmic lens, intraocular lens, and lens material
An ophthalmic lens includes a matrix and a natural yellow dye dispersed in the matrix. The natural yellow dye includes at least one of lutein and zeaxanthin..
Hon Hai Precision Industry Co., Ltd.
An ophthalmic surgical apparatus may include a tower extending upward from a support base, and a user-positionable arm extending from the tower to support an optical instrument attached to a distal end of the user-positionable arm. The user-positionable arm may include four members that are pivotably connected to each other.
System and inspecting opthalmic lenses
A system for inspecting an ophthalmic lens comprising an optical connection: an illumination source 60, wherein the light source is arranged to project the light to wards the ophthalmic lens held in the holder; an optical lens 83, wherein the lens is arranged to condition and project the light beam to illuminate the lens; a swivel glass plate 40, which is arranged to move in and out of the optical axis 110; a bright field imaging unit, wherein the bright field imaging unit is arranged to capture an image projected by the illumination source 60; a dark field imaging unit, wherein the dark field imaging unit is arranged to capture an image projected by the illumination source 60; and at least one camera sensor operatively coupled with the swivel glass plate, wherein the at least one camera sensor is arranged to capture an image of the light penetrating through the optical lens 83 contained at the bottom of the container 50 and the optical module 20 positioned in line with the optical axis 110.. .
Emage Vision Pte. Ltd
Semi-automated ophthalmic photocoagulation method and apparatus
An ophthalmic treatment system is configured to perform scanning of target tissue in a patient's eye to at least visualize the target tissue. The scanning pivots about a patient's iris to scan a retina..
Topcon Medical Laser Systems, Inc.
Contact lens mounting speculum for vitreoretinal surgery
A contact lens is placed on a patient's eye during ophthalmic surgery, such as vitreoretinal surgery. The contact lens rests on a cornea of an eye of a patient during the surgery and is supported by a contact lens mounting speculum having multiple degrees of freedom to accommodate small movements of the eye while enabling alignment to an optical axis of the surgical microscope.
Optical article comprising an antireflective coating with a very low reflection in the visible and ultraviolet regions
This invention relates to an ophthalmic lens comprising a transparent substrate with a front main face and with a rear main face, at least one of the main faces being coated with a multilayered antireflective coating comprising a stack of at least one high refractive index layer (hi) having a refractive index higher than or equal to 1.55 and at least one low refractive index layer (li) having a refractive index lower than 1.55, characterized in that: said at least one high refractive index layer (hi) is in direct contact with said at least one low refractive index layer (li) forming a bilayer, said bilayer has a physical thickness lower than or equal to 60 nm, said bilayer is, in the direction moving away from said transparent substrate, in second to last place in said multilayered antireflective coating, said multilayered antireflective coating has a mean reflection factor ruv between 280 nm and 380 nm, lower than 5% for an angle of incidence in the range from 20° to 50°.. .
Essilor International (compagnie Generale D'optique)
Antagonists of slc38a9 and their use in therapy
The present invention relates to an antagonist or modulator of slc38a9 for use in treating a disease associated with mtorc1 activation, like a proliferative disease (e.g. A cancerous disease or benign proliferative disease), a metabolic disorder, a disorder of the immune system, a disorder causing premature aging, an ophthalmic disorder or a neurological disorder.
Cemm - Forschungzentrum Fuer Molekulare Medizin Gmbh
Compounds for treating ophthalmic diseases and disorders
The present invention relates generally to the field of ocular therapeutics and the development thereof for use in humans or animals. More particularly, it relates to dhodh inhibitor compounds and their use for the treatment of ophthalmic diseases and disorders.
Panoptes Pharma Ges.m.b.h.
High concentration olopatadine ophthalmic composition
The present invention is an ophthalmic composition containing a relatively high concentration of olopatadine. The composition is typically an ophthalmic aqueous solution containing relatively high concentrations of olopatadine solubilized within the solution.
Alcon Research, Ltd.
Anti-aliasing photodetector system
An anti-aliasing photodetector system for a powered ophthalmic device, such as a contact lens, may be utilized for any number of functions. The anti-aliasing photodetector system converts current from an array of photodetectors into a voltage for use in other aspects of the powered ophthalmic device.
Johnson & Johnson Vision Care, Inc.
Ophthalmic treatment device, system, and use
ophthalmic treatment systems and methods of using the systems are disclosed. The ophthalmic treatment systems include (a) a light source device; (b) at least one optical treatment head operatively coupled to the light source device, comprising a light source array, and providing at least one treatment light; and (c) a light control device, which (i) provides patterned or discontinuous treatment light projection onto an eye (e.g., the cornea and/or sclera of an eye); or (ii) adjusts intensity of part or all of the light source array, providing adjusted intensity treatment light projection onto an eye (e.g., the cornea and/or sclera of an eye).
Cxl Ophthalmics, Llc
Topical formulations and uses thereof
Provided herein include formulations for topical administration, such as ophthalmic formulations, and methods of using such formulations. In some aspects and embodiments the formulations may include a polyoxyl lipid or fatty acid, and or a polyalkoxylated alcohol and may include nanomicelles.
Ocular Technologies Sarl
Ophthalmic formulations of mycophenolic acid
ophthalmic formulations including mycophenolic acid or salt thereof in an aqueous medium having a reduced level of dissolved oxygen and processes for making such formulations and using such formulations are disclosed.. .
Insite Vision Incorporated
An ophthalmic device is configured to examine at least two eye characteristics including intraocular pressure, and the ophthalmic device includes: an examination optical system configured to obtain information of a subject's eye when the at least two eye characteristics of the subject's eye are examined; and an examination window configured to switch examinations of the at least two eye characteristics. The examination optical system is arranged outside of the examination window.
Ophthalmic imaging device and ophthalmic imaging program
An ophthalmic imaging device that captures an image of a test eye, the device includes: an oct optical system configured to acquire an oct signal by scanning a tissue of the test eye with measurement light, the ophthalmic imaging device configured to execute: receiving a designation of a wide area which is wider than a unit area which is an acquisition unit for acquiring motion contrast data indicating a motion of the tissue; acquiring a plurality of oct signals for the same position at different timing in each of a plurality of unit areas, the plurality of unit areas being positioned in the designated wide area and being not completely overlapped with each other; and acquiring the motion contrast data of each of the plurality of unit areas by processing the plurality of oct signals acquired for the same position.. .
Nidek Co., Ltd.
An ophthalmic apparatus includes a deforming unit and a generation unit. The deforming unit deforms a shape of a boundary that defines a region of a tomographic image of a subject eye in a depth direction according to a thickness of a layer in which the boundary is positioned.
Canon Kabushiki Kaisha
Ophthalmic device, method and system
The present invention relates to an eye testing and image capture device for testing and examination of an eye comprising an image display device to display an image for viewing by an eye to be tested; an image capture device to capture an image of the eye; a beam splitter positioned to split light between the image capture device and the image display device; and a lighting array for illuminating the eye wherein the lighting array comprises a first array positioned at a first angle to the eye and a second array positioned at a second angle to the eye and the first array and second array comprise two or more different light types. The present invention also relates to a method of obtaining eye test data and one or more image of an eye as well as to a system and method of screening a patient using the device and method..
Ingeneus Pty Ltd
Methods of obtaining ophthalmic lenses providing the eye with reduced aberrations
The present invention discloses methods of obtaining ophthalmic lens capable of reducing the aberrations of the eye comprising the steps of characterizing at least one corneal surface us a mathematical model, calculating the resulting aberrations of said corneal surface(s) by employing said mathematical model, selecting the optical power of the intraocular lens. From this information, an ophthalmic lens is modeled so a wavefront arriving from an optical system comprising said lens and corneal model obtains reduced aberrations in the eye.
Amo Groningen B.v.
Wavefront generation for ophthalmic applications
Embodiments of this invention relate to the generation of wavefronts for measurements, diagnostics, and treatment planning for ophthalmic applications. In some embodiments, a wavefront generator generates light having a uniform wavefront, which is focusable on the retina of an emmetropic eye by the normal function of the emmetropic eye.
Amo Groningen B.v.
Variable optic ophthalmic device including liquid crystal elements
Methods and apparatuses for providing a variable optic insert into an ophthalmic lens as set forth. An energy source is capable of powering the variable optic insert included within the ophthalmic lens.
Johnson & Johnson Vision Care, Inc.
The present invention provides an ophthalmic composition comprising polysorbate 80 and a refreshing agent, wherein a polydispersity of the polysorbate 80 in the ophthalmic composition is 1.00 to 1.26.. .
Rhoto Pharmaceutical Co., Ltd.
Systems and methods for enhanced occlusion removal during ophthalmic surgery
A method and apparatus for performing a surgical procedure is provided. The surgical procedure may be a phacoemulsification procedure but other procedures may employ the techniques disclosed.
Abbott Medical Optics Inc.
Sub-micron alignment of a monitoring fiber for optical feedback in an ophthalmic endo-illumination system
An ophthalmic endo-illumination system includes a light source producing a light beam, a beam splitter configured to split the light beam into a first beam provided to a fiber port and a second beam coupled to a monitoring fiber, and an alignment system for aligning the monitoring fiber. The alignment system includes a moveable ferrule housing having the monitoring fiber secured therein and a displacement mechanism for displacing housing in a first direction.
Ophthalmic apparatus, information processing method, and storage medium
An ophthalmic apparatus includes a generation unit configured to generate 3d blood vessel data indicating a blood vessel in a fundus based on a plurality of tomographic image data indicating cross sections of the fundus, a boundary obtaining unit configured to obtain layer boundary data indicating at least one layer boundary based on 3d tomographic image data including the plurality of tomographic image data indicating the cross sections of the fundus, and a determination unit configured to determine a blood vessel intersecting with the layer boundary by comparing the 3d blood vessel data with the layer boundary data.. .
Canon Kabushiki Kaisha
Method for molding an ophthalmic lens and device for applying a coating to the surface of an ophthalmic lens mold
Also described is a device (1) for applying such temporary coating to the portion of the lens forming surface (21) of the ophthalmic lens mold.. .
Crosslinked gels comprising polyalkyleneimines, and their uses as medical devices
One aspect of the present invention generally relates to methods of sealing a wound or tissue plane or filling a void splace. In a preferred embodiment, the wound is an ophthalmic, pleural or dural wound.
Hyperbranch Medical Technology, Inc.
Pharmaceutical composition for treating or preventing corneal wound comprising thymosin beta 4 and citric acid
The present invention relates to a composition for the treatment or prevention of a corneal injury, which comprises thymosin β4, and citric acid or its salt as active ingredients. The composition may further comprise at least one organic acid selected from acetic acid, ascorbic acid or salts thereof.
G-treebnt Co., Ltd.
The present invention relates to an ophthalmic formulation which comprises a fine particle of compound a in an aqueous suspension and a manufacturing process thereof. More specifically, the present invention relates to a topically applied ophthalmic aqueous suspension which is obtainable by suspending fine particles of compound a in an aqueous vehicle containing a surfactant and boric acid.
Inotek Pharmaceuticals Corporation
Mtor pathway inhibitors for treating ocular disorders
Diseases and conditions associated with tissues of the body, including but not limited to tissues in the eye, can be effectively treated, prevented, inhibited, onset delayed, or regression caused by administering therapeutic agents to those tissues. Described herein are ophthalmic formulations that deliver a variety of therapeutic agents, including but not limited to rapamycin (sirolimus), analogs thereof (rapalogs) or other mtor inhibitors, to a subject for an extended period of time.
Santen Pharmaceutical Co., Ltd.
Alkoxy compounds for disease treatment
The present invention relates generally to compositions and methods for treating neurodegenerative diseases and disorders, particularly ophthalmic diseases and disorders. Provided herein are alkoxyl derivative compounds and pharmaceutical compositions comprising these compounds.
Epinephrine-based ophthalmic compositions for intraocular administration and methods for fabricating thereof
Pharmaceutical compositions for intraocular injection are described, the compositions comprise therapeutically effective quantity of lyophilized preservative-free and sulfite-free epinephrine or adrenaline and a metal chelator. Methods for fabricating the compositions and using them for intraocular injections are also described..
Imprimis Pharmaceuticals, Inc.
Surgical microscope with integrated optical coherence tomography and display systems
An ophthalmic surgical microscope includes a beam coupler positioned along an optical path of the surgical microscope between a first eyepiece and magnifying/focusing optics, the beam coupler operable to direct the oct imaging beam along a first portion of the optical path of the surgical microscope between the beam coupler and a patient's eye (an oct image being generated based on a reflected portion of the oct imaging beam). The surgical microscope additionally includes a real-time data projection unit operable to project the oct image generated by the oct system and a beam splitter positioned along the optical path of the surgical microscope between a second eyepiece and the magnifying/focusing optics.
Hood for an ophthalmic device
The present invention describes a rectangular parabolic hood for blocking accommodation and reducing depth of focus to offset the negative affects of extraneous light and visual stimulus during examination of the pupil using ophthalmic instruments.. .